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The essential oil of the leaves of Eugenia sulcata, in the Myrtaceae family, has a demonstrated 
antihypertensive effect, but its effects on heart muscle and its toxicity have not yet been elucidated. Little 
chemical or biological data are available for E. sulcata, whether emphasizing the beneficial effects or 
the pharmacological security of this species. This study aims to evaluate myocardial contractility and 
to analyze angiotensin converting enzyme (ACE) and myosin ATPase activities associated with use 
of this essential oil. In addition, we evaluated the immunotoxicity of E. sulcata essential oil. Wistar 
Kyoto (WKY) and spontaneously hypertensive rats (SHR) were treated daily for 30 days (10 mg/kg of 
oil) to evaluate the isometric force of the papillary muscle, ACE measured by fluorimetry, and myosin 
ATPase activities by inorganic phosphate. Lymphocyte cultures were used to evaluate cytotoxicity, DNA 
damage, and mutagenicity of the essential oil. The results demonstrate that the treatment did not change 
the cardiac contraction force and did not alter the functioning of the sarcoplasmic reticulum, extrusion 
of the membrane calcium, or modify the membrane calcium channels or β-adrenergic receptor activity. 
Tetanic contractions were potentiated in the SHR animals. Myosin ATPase activity was also increased 
in the SHR animals. Cardiac ACE activity was reduced in both animal strains, and the serum ACE 
was reduced only in the SHR animals. The essential oil did not cause cytotoxicity or mutagenicity and 
presented low DNA damage. Our results demonstrated that the essential oil does not change myocardial 
contractility and does not present relevant immunotoxicity. 
Keywords: Myrtaceae/adverse effects. Angiotensin-Converting Enzyme Inhibitors/immunology. 
INTRODUCTION
Many medicinal plants are used by the human 
population for the treatment of pathologies affecting the 
cardiovascular system, such as hypertension. However, 
the safety, effectiveness, and mechanism of action have 
been scientifically confirmed for only a few of these plants 
(Vora, Mansoor, 2005). Eugenia sulcata Spring ex Mart. 
(family Myrtaceae) is an endemic species of the Atlantic 
Rainforest and popularly used for diarrhea and fever 
(Cruz, Kaplan, 2004); it is commonly known as murtinha 
or murta preta in Restinga de Jurubatiba National Park 
(Santos et al., 2009). 
Previous studies carried out by our group have 
demonstrated the hypotensive and antihypertensive effect 
(Santos et al., 2013, 2014) and anticholinesterase activity 
(Lima et al., 2012) of E. sulcata essential oil. Lima et al. 
(2012) analyzed the constituents in essential oil from the 
leaves of E. sulcata and found 22 components, mainly α 
and β pinene, β caryophyllene, and 1.8 cineol, and these 
compounds could be involved in these activities. 
It is known that clove oil contains β caryophyllene 
oxide and eugenol, and when analyzing the force of cardiac 
contraction, a significant decrease was observed in treated 
animals (Sensch et al., 2000). There are few chemical, 
biological, or toxicological scientific studies of E. sulcata, 
and there are no studies to evaluate the pharmacology and 
toxicology of this oil to ensure its safety and efficacy.
Several factors are involved in hypertension, and key 
enzymes have been considered in relation to this pathology. iD
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Activation of the renin–angiotensin–aldosterone system 
(RAAS) is one of the most important mechanisms 
contributing to endothelial cell dysfunction, hypertension, 
and vascular remodeling (Ferrario et al., 2014). Renin and 
angiotensin-I converting enzyme (ACE) are the two key 
enzymes that regulate the renin–angiotensin system, and 
they are important determinants of blood pressure and 
fluid homeostasis (Daien et al., 2012). Reports of plant 
essential oils and extracts with inhibitory action in ACE 
activity indicate that they could be a promising therapeutic 
adjuvant (Mansour et al., 2013; Jaarin et al., 2015; Sharifi 
et al., 2013). 
One of the organs most affected by hypertension is 
the heart. Several pathological cardiac events arising from 
both volume and pressure overload or metabolic changes 
can trigger modifications in myocardial contractility 
proteins. The major molecules involved in the contraction–
relaxation cycle are the two main contractile proteins: the 
thin segment, actin, and the thick segment, myosin. The 
cycle of contraction occurs, in terms of biochemistry, 
through the hydrolysis of adenosine triphosphate (ATP) 
on adenosine diphosphate (ADP) and inorganic phosphate 
(Pi) by the ATPase activity of the myosinic head flexing 
it (Libby et al., 2008). 
The use of plants in therapeutic regimens has been 
increasing over the years. It is estimated that Brazil has 
the greatest genetic diversity on the planet (Almeida, 
2003), and it is a rich source of plant inputs that can aid 
in the treatment and prevention of many diseases (Simões 
et al., 2007). Despite their great medicinal importance, 
the toxicity of most Brazilian plants is not known, 
making it a research area that should be incentivized. 
Our study therefore evaluates myocardial contractility 
and immunotoxicity in human lymphocytes in order to 
increase the available knowledge about E. sulcata.
MATERIAL AND METHODS
Plant material
Leaves of Eugenia sulcata were collected in 
Restinga of Jurubatiba National Park, Rio de Janeiro 
State, Brazil, from Clusia scrub vegetation (22°12’57.7”S 
41°34’58.5”W) in July 2013. A voucher specimen was 
deposited at the herbarium of the Faculdade de Formação 
de Professores (Universidade do Estado do Rio de 
Janeiro, Brazil) under the register number RFFP 13.788. 
The extraction of the oil and the identification of the 
components were carried out according to Lima et al. 
(2012).
Animals
A total of 16 male Wistar Kyoto (WK) rats and 
16 spontaneously hypertensive rats (SHR), 200–250g 
weight and 12 weeks old, were purchased from Fundação 
Estadual de Produção e Pesquisa em Saúde (FEPPS) and 
were maintained in the Federal University of Pampa, 
campus Uruguayana, RS, Brazil. They were used after 
acclimatization for 1 week. They were kept under 
conditions of constant temperature (22–25°C) with an 
artificial 12h light/dark cycle; all rats received food and 
water ad libitum. The experimental protocol was carried 
out according to the COBEA guidelines (Brazilian College 
of Animal Experimentation) and was approved by the 
Animal Ethics Committee of the Federal University of 
Pampa (No. 34/2015). 
Experimental groups
Rats were divided into four experimental groups of 
eight rats each. Two control groups of WKY rats and SHR 
rats received dimethyl sulfoxide (DMSO, 0.5% in saline, 
i.p. used as vehicle). Two treated groups of WKY rats and 
SHR rats received essential oil diluted in the vehicle. Rats 
were treated for 30 days with daily dose injections (10 mg/
kg, i.p.) in a final volume of 200 µL (Santos et al., 2014). 
The treatment time and the dose used were based 
on previous studies with E. sulcata (Santos et al., 2013; 
2014).
Myocardial contractility
The animals were anaesthetized (75 mg/kg ketamine 
and 100 mg/kg xylazine), and the chest was opened to 
collect the heart. The papillary muscles of the left ventricle 
(LV) were dissected and placed on a nourishing solution 
(20 mL) of Krebs–Henseleit buffer, pH 7.4, aerated with 
5% CO2 and 95% O2 at 29°C. The muscles were fixed by 
rings, tied to a fixed end, and attached to a force transducer. 
The papillary muscles were electrically stimulated through 
a pair of platinum electrodes positioned along the entire 
length of the muscle (rectangular pulses with duration of 
12 milliseconds and voltage 1.5 times the threshold), with 
stimulation frequency of 0.5 Hz, and the muscles were 
stretched to Lmax (muscle length at which the maximum 
voltage is active). The preparations were maintained for 
a 30-minute stabilization period before initiation of the 
experimental protocols.
Isometric force
The force developed was normalized by the muscle 
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weight (g/mg muscle) and measured by means of an 
isometric force transducer (TSD125, Biopac Systems, 
Inc., CA) coupled to an amplifier (DA100C, Biopac 
Systems, Inc., CA) and recorded by a data acquisition 
system (BIOPAC MP100 Systems, Inc., CA) connected to 
a microcomputer. The data were recorded at 500 samples/
second.
Potentiation after pauses
The relative potentiation after pauses of 15, 30, and 
60 seconds was obtained in order to indirectly evaluate 
the contribution of sarcoplasmic reticulum (SR) in 
contraction. The ratio of the amplitude of contraction after 
the pause and the amplitude of the previous contraction to 
the pause was considered.
Frequence of stimulation
The strength was developed in different frequencies 
of electrical stimulation in the papillary muscles (from 0.1 
to 1.0 Hz).
Inotropic effect of calcium
The inotropic dose-response curve to calcium in 
increasing concentrations of CaCl2 (0.62; 1.25; 2.50 
and 3.75 mM) was measured. Response to calcium was 
measured in g/mg.
Beta-adrenergic response
The beta-adrenergic response to isoproterenol (10-5 
M) evaluates the interference of treatment on β-adrenergic 
response in the heart muscle. It was normalized as the ratio 
of the maximum amplitude in the force of contraction in the 
presence of isoproterenol and the amplitude to contraction 
previous isoproterenol (Leite, Vassallo, Millet, 1995).
Tetanic contractions
Assessment of the effects of the essential oil on 
tetanic contractions was obtained after 30 minutes of 
treatment with 5 mM caffeine at a frequency of 10 Hz and 
duration of 15 seconds, as previously described (Vassallo 
et al., 2008).
Heart hypertrophy analysis
The animals’ body weight was measured daily. 
The right ventricle was separated from the LV, and 
interventricular septum was considered part of the LV. 
The ratio of ventricular weight to body weight (LV/BW) 
was used as an index for estimation of cardiac hypertrophy 
as described by Piratello et al., 2010, and Campos et al., 
2015.
Evaluation of the specific activity of myosin 
ATPase
The preparation of the myosin fraction was 
performed according to Bremel and Weber (1975) and 
described by Moreira et al. (2003). Part of the LV of 
the rats after treatment was homogenized in 150 mM 
phosphate buffer solution containing 0.6 M KCl, pH 6.5 
(this procedure solubilizes myosin), precipitated with 
the slow addition of water, centrifuged at 30,000 × g for 
30 min. The precipitate was solubilized in phosphate buffer 
with 0.6 M KCl and again centrifuged at 30,000 × g for 
30 min. These centrifugation procedures were performed 
two more times. The latter precipitate was resuspended 
in 50 mM HEPES, pH 7.0, 0.6 M KCl, and 50% (v/v) 
glycerol, then aliquoted and stored at −80°C. 
For the biochemical evaluation of the heart’s ability 
to generate contractile force, the myosin ATPase activity 
was determined using a buffer medium (pH 7.0) containing 
50 mM HEPES, 5 mM CaCl2, 0.6 M KCl, and 1 mM ATP 
(Moreira et al., 2003). The incubation time and amount 
of protein added to the reaction medium were chosen to 
ensure the linearity of product formation at 30°C. The 
reaction was initiated by the addition of the myosinic 
fraction. The reaction was stopped by the addition of 
trichloroacetic acid (TCA) to a final concentration of 5%. 
The final product in the reaction was inorganic phosphate 
(Pi), which was measured according to the method of 
Chan, Delfert, and Junger (1986). Samples were assayed in 
triplicate, with the non-enzymatic hydrolysis corrected by 
controls made under the same sample conditions, except 
that the enzymatic fraction was added after discontinuation 
of the TCA reaction. The specific activity was expressed 
in nmol of phosphate released per minute and per mg 
of protein (nmol Pi/min/mg). Protein was quantified by 
the method of Bradford (1976) using bovine albumin 
(1 mg/mL) as standard.
Angiotensin converting enzyme activity
The effect of the essential oil in ACE activity was 
determined as previously described by Oliveira, Santos, 
and Krieger (2000). The animals’ blood was collected 
from the abdominal aorta, and serum samples were 
incubated in 40 μL buffer (0.4 M sodium borate, 0.9 M 
NaCl, pH 8.3), 5μL substrate hippuryl-histidyl-leucine 
(5 mM Hip-His-Leu) for 15 min at 37°C. The reaction 
was stopped by adding 190 μL of 0.34 N NaOH. The 
Hip-His-Leu product was measured by fluorometry at 
365 nm excitation and 495 nm emission after the addition 
of 17 μL of o-phthaldialdehyde (2%) in methanol. To 
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correct the intrinsic fluorescence of the serum, blanks were 
included by adding Hip-His-Leu and o-phthaldialdehyde. 
For cardiac ACE determination, part of each animal’s LV 
was homogenized in borate buffer (100 mg tissue/mL 
buffer). Samples (10 μL) were incubated as described 
above for serum ACE. The calibration curve with the 
product (Hip-His-Leu) was included in each experiment.
Culture cell preparation
Lymphocyte cultures were prepared with human 
whole-blood samples and immediately transferred to 10 mL 
of culture medium containing RPMI 1640 supplemented 
with 10% fetal bovine serum and 1% streptomycin/
penicillin, as previously described (Santos-Montagner 
et al., 2010). The Research Ethics Committee of the 
Federal University of Pampa (No. 27045614.0.0000.5323) 
approved the use of human blood. Cells were maintained 
at 37°C in a 5% CO2 environment. Every 72h, the medium 
was exchanged with another prepared in the same manner. 
Cells were maintained in this manner until the time of use. 
All cultures received the addition of the test compound in 
a final volume of 100 μL. The groups to be tested were: 
negative control (NC) with phosphate buffer (PBS) pH 7.4, 
genotoxic positive control (PC) with hydrogen peroxide 
(H2O2) (10 μM), and 3 concentrations of E. sulcata (ES) 
essential oil (1, 10, and 100 μg/mL).
Immunotoxicological analysis 
To perform the genotoxicity tests, we first counted 
the total number of lymphocytes in a Neubauer chamber 
(Santos-Montagner et al., 2010). Viability was assessed by 
loss of membrane integrity, which was indicated with trypan 
blue (Burow et al., 1998). Overall, we counted 300 cells. The 
genotoxicity test was conducted using comet assay (Singh 
et al., 1995). Although comet assay is not the only method 
for measuring oxidative DNA damage, it is one of the most 
sensitive and accurate and is relatively free of artifacts. 
The cells were visually scored according to tail length, 
with scores ranging from 0 (no migration) to 4 (maximal 
migration). The damage index for cells therefore ranged from 
0 (all cells with no migration) to 400 (all cells with maximal 
migration). The micronucleus test was the parameter used 
to evaluate mutagenicity. The method was performed 
according to the technique described by Schmid (1975) 
and presented in index form as described by Fenech (2000). 
Statistical analysis
The results were expressed as mean ± mean 
standard error (M ± SEM). The values were analyzed 
using a two-way ANOVA (Figures 1A–1F and 3) and 
unpaired Student’s t-test (Figures 1H and 2), with post hoc 
Bonferroni. Mean differences were considered statistically 
significant with p < 0.05.
RESULTS
Myocardial contractility
The isometric force exerted by the papillary muscle 
of the LV is shown in Figure 1A. The results demonstrate 
that treatment with the essential oil of E. sulcata leaves 
did not impair the force of cardiac contraction. There was 
no difference in calcium inotropic effect with treatment, 
suggesting that the essential oil of E. sulcata did not 
interfere in the membrane calcium channels (Figure 1B). 
In relative potentiation after pauses, Figures 1C and 1D 
show that at the times of 15, 30, and 60 seconds, there was 
no change in the force developed. The force developed 
in the different frequency of electrical stimulation shows 
that there was no change in the two rats strains tested 
(Figure 1E and 1F). The administration of isoproterenol 
(β-adrenergic agonist) did not increase the force developed 
by the papillary muscles (Figure 1G). Figure 1H shows 
tetanic cardiac contractions, where it was observed that 
they were potentiated in hypertensive and WK rats.
Heart hypertrophy analysis
In the index of cardiac hypertrophy, a decrease in 
the VE/body weight ratio was observed in both SHR and 
WK animals (Figure 2A).
Evaluation of the specific activity of myosin 
ATPase
Figure 2B demonstrates a significant increase of 
myosin ATPase-specific activity in hypertensive animals 
treated with essential oil from E. sulcata leaves.
Angiotensin converting enzyme activity
The activity of the angiotensin-converting enzyme 
was assessed in cardiac tissue and serum. There was a 
decrease in cardiac activity in SHR and WK; however, in 
serum ECA there was decrease only in SHR treated with 
essential oil from E. sulcata leaves (Figures 2C and 2D).
Immunotoxicological analysis
Figure 3A shows the cell viability for human 
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FIGURE 1 - Myocardial contractility of the Left ventricle (LV) papillary muscle of rats treated for 30 days with the essential 
oil of Eugenia sulcata leaves (10 mg/kg). Legend: (A) Isometric force. (B) Inotropic effect of calcium (0.62 - 3.75 mM CaCl2). 
(C) Relative potentiation after pauses (15, 30, and 60 s) in Wistar Kyoto (WK). (D) Relative potentiation after pauses (15, 30, 
and 60 s) in spontaneously hypertensive animals (SHR). (E) Strength of the different frequencies of electrical stimulation in WK. 
(F) Strength of the different frequencies of electrical stimulation in SHR. (H) Tetanic contractions. *p<0.05 vs Control. ANOVA 
and Student’s t-Test.
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lymphocytes treated with different concentrations of 
E. sulcata essential oil. It was verified that the positive 
control (PC) reduced cell viability by 11% compared to 
the negative control (NC) whereas no effect was detected 
with the oil treatment. In the mutagenicity analysis 
that tested for the frequency of micronuclei for human 
lymphocytes, there were no statistical differences in the 
concentrations of the essential oil when compared to the 
NC, and all the concentrations of the oil were significantly 
different from the PC, showing no mutagenicity (Figure 
3B). Figure 3C, which evaluates the DNA damage index 
through the comet test, shows a difference between the 
NC and PC groups and indicates that all concentrations 
of the oil of E. sulcata leaves showed significant damage 
when compared to the NC group. However, the oil in the 
different concentrations shows an increase in the DNA 
damage index of a maximum of 50% when compared to 
the PC. 
DISCUSSION
The isometric force of the papillary muscle was 
used to evaluate the myocardial contractility of the LV 
papillary muscles in animals treated with E. sulcata oil 
for 30 days. It was observed that treatment did not modify 
the force in either WK or SHR animals, demonstrating 
that there was no impairment in myocardial contractility 
at the concentration used and in the evaluated period 
(Figure 1A).
A negative inotropic effect has been observed in 
mice with the administration of the essential oil of the 
leaves of Schinus areira L., the main constituents of 
which are β caryophyllene and α pinene (Bigliani et al., 
2012). Although E. sulcata essential oil has the same 
major constituents, it did not decrease the force of cardiac 
contraction in this study. However, this oil is able to 
reduce blood pressure in hypertensive animals (Santos et 
al., 2014) without causing damage to cardiac contraction 
force.
In the myocardium, the influx of Ca2+ stimulates 
the release of Ca2+ from the intracellular stock of SR, 
with subsequent transient increase of the intracellular 
concentration of Ca2+, which results in the activation of 
myofilaments, producing muscle contraction (Bers, 2002). 
Calcium plays a crucial role in regulating the contraction 
and relaxation phase of the cardiac muscle. The increase 
in the concentration of cytosolic calcium also causes its 
interaction with troponin C to increase and activates the 
contractile process; that is, the greater the amount of 
available calcium, the greater the force generated (Bers, 
FIGURE 2 - Evaluation of the cardiac hypertrophy index and biochemical evaluations in rats treated for 30 days with the essential 
oil of the leaves of Eugenia sulcata (10 mg/kg). Legend: (A) LV cardiac hypertrophic index. Left Ventricular Weight/Body Weight 
(LV/BW) (B) Myosin ATPase activity in LV myosin preparations. (C) Serum angiotensin converting enzyme activity (ACE). (D) 
Activity of the ACE in the LV homogenate. *p<0.05 vs Control and #p<0.05 vs WK Control. Student’s t-Test). 
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2002). There was no difference in the calcium inotropic 
effect with treatment, suggesting that the essential oil 
of E. sulcata did not interfere in the membrane calcium 
channels (Figure 1B).
Post pause potentiation (PPP) was performed to 
determine whether essential oil could interfere with the 
function of the SR, an important organelle in the generation 
of contractile force. It is known that in mammalian cardiac 
muscles the first contraction is potentiated after a short 
pause period (Vassallo et al., 2008). 
The contractions obtained after pauses are more 
dependent on the release of calcium by their intracellular 
stokes than by the influx of calcium by the sarcolemma. 
In this way, PPP measurements aim to evaluate the 
activity of SR, both in terms of the magnitude of release 
of activating calcium and the capacity of calcium reuptake 
(Mill et al., 1994). It was observed that E. sulcata oil did 
not modify the SR function, since at all tested times (15, 
30, and 60 seconds) there were no significant differences 
in the strength developed by the treated animals (Figure 
1C and 1D).
The force developed at different frequencies of 
electrical stimulation can be objectively assessed in 
papillary muscles if calcium-extruding mechanisms 
are preserved in the LV. No change was observed in 
the development of strength at different frequencies of 
electrical stimulation of the animals in both experimental 
groups (Figure 1E and 1F); therefore, we can suggest 
that the myocytes of those rats treated for 30 days had 
unchanged calcium extrusion mechanisms (Mill et al., 
1994).
The beta-adrenergic activation of the heart muscle 
culminates in the phosphorylation of membrane calcium 
channels and ryanodine channels, leading to an increase 
in intracellular calcium (Negroni et al., 2015). As shown 
in Figure 1G, treatment with E. sulcata showed no change 
in this parameter.
The cardiac muscle action potential is long, which 
prevents the myocyte from suffering re-stimulation 
and tetanization, so cardiac tetanus cannot be reached 
in normal conditions. Caffeine was used to tetanize the 
cardiac muscle, which depletes calcium SR to keep open 
the ryanodine channels (Bassani, Bassani, Bers, 1994). 
The frequency of electrical stimulation at 10 Hz was 
used to stimulate the maximal activation of the cardiac 
machine of the papillary muscles (Leite, Vassallo, Millet, 
1995). The tetanic contraction occurs via transmembrane 
calcium channel inflow (because the ryanodine channels 
does not function) and by sensitization of contractile 
proteins (Leite, Vassallo, Millet, 1995). The essential oil 
treatment showed an increase in tetanic contraction force, 
FIGURE 3 - Immunotoxicological analysis of the essential oil 
treatment of Eugenia sulcata leaves (1, 10, and 100 µg/mL) 
on human lymphocytes. Legend: Eugenia sulcata (ES), 
negative control with phosphate buffer (PBS) (NC), positive 
control with hydrogen peroxide (H2O2) (PC). (A) Cell viability 
assessment. (B) Evaluation of DNA damage index by comet 
assay. (C) Micronucleus frequency evaluation. *p<0.05 vs PC 
and #p<0.05 vs NC. ANOVA.
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which suggests that it can influence the sarcolemmal entry 
calcium and/or the sensitivity of myofilaments, (Figure 
1H). 
In hypertensive patients, left ventricular hypertrophy 
(LVH) is a powerful independent predictor of morbidity 
and mortality (Tamargo, Delpón, Valenzuela, 1993). The 
weight ratio LV/BW is considered an index of ventricular 
hypertrophy. The essential oil treatment was capable 
of decreasing the LV/BW ratio in treated SHR and also 
in treated WK animals (Figure 2A), demonstrating 
hypotrophic and antihypertrophic effects. The animals 
were monitored daily (data not shown), and there was 
no significant difference in body weight for either group 
during the treatment time.
Myosin is a contractile protein that changes the 
expression of its heavy chain isoforms (alpha to beta 
MHC) with a pressure overload in an attempt to maintain 
force generation. The alpha-MHC isoform has an ATP 
hydrolysis rate greater than the beta-MHC isoform (Barany 
1967; Hoh et al., 1979; Syrovy, Delcayre, Swynghedauw, 
1979). Some essential oils exhibit a negative inotropic 
effect without altering the activity of myosin (Damiani et 
al., 2004), but E. sulcata oil did not alter the contraction 
force (Figure 1A), possibly due to the increase in myosin 
activity, preserving the alpha MHC isoforms (Barany, 
1967).
Figure 2B demonstrates a myosin ATPase-specific 
activity of the rats treated with essential oil from E. sulcata 
leaves. It was observed that there was a significant increase 
in enzyme activity in hypertensive animals, suggesting an 
improvement in the percentage of isoforms with the higher 
ATP rate (alpha-MHC).
We observed that the cardiac ACE activity showed 
a significant decrease in both the WK and SHR treated 
animals, and when ACE was measured in serum, there 
was a significant decrease only in hypertensive animals, 
meaning that E. sulcata essential oil showed an inhibition 
of ACE activity, as shown in Figures 2C and 2D. Inhibition 
of ACE activity results in lower production of Angiotensin 
II, which is a potent vasoconstrictor; thus it is able to 
contribute to the regulation of blood pressure and cardiac 
muscle integrity. Other essential oils also show inhibition 
of ACE in experimental animals (Mansour et al., 2013; 
Jaarin et al., 2015).
The  e s sen t i a l  o i l  o f  E.  su l ca ta  p r e sen t s 
antihypertensive effect (Santos et al., 2014), and, to our 
knowledge, this study demonstrates for the first time 
the evaluation of relevant cardiac enzymes and cardiac 
mechanics. Although the essential oil did not alter the 
contraction force, it showed an increase in the activity of 
the force-generating enzyme (myosin ATPase) and in the 
enzyme involved in the antihypertensive activity (ACE), 
which suggests that this essential oil can be used for the 
treatment of hypertension while preserving myocardial 
contractility.
The cell viability for human lymphocytes, shown 
in Figure 3A, was tested at three concentrations of E. 
sulcata essential oil. It was verified that, while the positive 
control (PC) decreased cell viability, this reduction in 
cell viability was not observed with essential oil when 
compared to the negative control (NC). These results show 
that the oil had no cytotoxic effect at the concentrations 
tested. When investigating the cytotoxic effect of the 
α pinene compound, 50 μg/mL cultures of fibroblasts, 
the authors found low cytotoxicity (Sobral-Souza et 
al., 2014). The hydroalcoholic extract of Euphorbia 
tirucalli was evaluated in a leukocyte cell culture, and 
the authors demonstrated that there was an increase in 
the percentage of non-viable cells with the increase of 
extract concentrations that were administered, showing 
a cytotoxic effect at high concentrations of E. tirucalli 
(Machado et al., 2016). Machado et al. (2016) has in 
its research the basis of the use of the trypan test, which 
supports both the evaluation of cytotoxicity per se and the 
need, as a screening test, to give reliability to the results of 
other tests, especially genotoxicological tests. However, 
the trypan blue test is limited to an assessment of cell 
membrane damage, so it does not exclude the possibility 
that other metabolic-functional mechanisms are present 
or support cytotoxicity results.
The  f requency of  micronucle i  for  human 
lymphocytes was tested for mutagenicity (Figure 3B). 
The treatment appeared to have no mutagenic effect for 
lymphocytes. Corroborating our data, Turkez and Aydin 
(2016) evaluated the effect of human lymphocyte exposure 
to α pinene, which did not undergo significant changes. 
In contrast, Catanzaro et al. (2012) demonstrated that α 
pinene, to promote significant changes in the frequency 
of micronuclei, as well as the hydroalcoholic extract of 
E. tirucalli, showed a higher frequency of micronuclei, 
indicating a genotoxic risk (Machado et al., 2016).
Evaluation of the DNA damage index (Figure 
3C) was performed through the comet test. The tested 
concentrations of essential oil yielded significant damage 
when compared to the negative control. However, this 
oil caused less damage to DNA than hydrogen peroxide 
(PC), thus demonstrating a low genotoxicity at the 
concentrations tested. 
Our immunotoxicity results, although presenting 
low DNA damage, did not show cytotoxic effects, did 
not present mutagenicity, and thus E. sulcata could be 
considered a potentially safe essential oil for use in 
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cardiovascular diseases. Even though there are some 
studies in the literature using medicinal plants, studies 
on essential oils still have not sufficiently verified the 
possible toxic effects of plants that are commonly used 
by the population. 
CONCLUSION
The essential oil of the leaves of E. sulcata does not 
change the isometric force generation capacity in the SHR 
and WK treated animals, demonstrating that there was 
no impairment in the myocardial contractility; however, 
tetanic contractions were potentiated in the SHR animals, 
and there was improvement in myosin ATPase activity 
and inhibition of ACE activity. This oil were found not 
to cause cytotoxicity or mutagenicity, and it showed low 
genotoxicity. In summary, the essential oil of the leaves 
of E. sulcata at a concentration of 10 mg/kg was shown 
to be beneficial to the cardiovascular system of rats and 
presented low immunotoxicity in human lymphocytes.
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